Uses of undefined

Poractant alfa is a synthetic surfactant used to treat Respiratory Distress Syndrome (RDS) in premature infants. It is also used to prevent RDS in premature infants at high risk for the condition. Some researchers are studying the use of this medication to treat other lung diseases, such as acute respiratory distress syndrome (ARDS) in adults.

undefined Drug administaration and Dosage available

Poractant alfa is administered through a breathing tube into the infant's lungs. This is called endotracheopulmonary administration. It is a relatively simple procedure that can be done in a hospital setting.

Warnings, Precautions and Side Effects of undefined

Warnings

Infants with surfactant protein B deficiency do not produce enough surfactant, and  Poractant alfa will not be effective in these infants. Infants with a history of bleeding disorders may be at an increased risk of developing complications with  Poractant alfa. This medication can also cause fever, infection, and jaundice. It can cause serious allergic reactions, including anaphylaxis can further cause difficulty breathing, hives, and swelling. 

Precautions

One should consult a health care provider before starting Poractant alfa in infants with a history of allergic reactions. Infants with surfactant protein B deficiency should not take this medication. You should tell your doctor immediately if your infant experiences other side effects like fever, infection, and jaundice. It is important to talk to your doctor about all of the risks and benefits of this medication before your infant receives it.

Side Effects

The most common side effects of  Poractant alfa are bradycardia (slow heart rate), hypotension (low blood pressure), hypoxemia (low oxygen levels in the blood), apnea (temporary cessation of breathing), respiratory distress, and thrombocytopenia (low platelet count). Other side effects include allergic reactions, fever, infection, jaundice, and seizures.

Word Of Advice

When receiving  Poractant alfa, it is important to tell your doctor about your medical conditions and medications. Be aware of the signs and symptoms of an allergic reaction, such as hives, swelling, difficulty breathing, or rash. Contact your doctor immediately if you experience any of these symptoms. A healthcare professional should administer it, and you should monitor yourself or your baby for any signs of problems, such as breathing problems, jaundice, or allergic reactions. Do not try to administer this medication yourself. Be aware of the signs and symptoms of an allergic reaction, bleeding, respiratory distress, apnea, and liver problems, and contact your doctor immediately if you experience any of these symptoms. Be aware of the signs and symptoms of apnea, such as a temporary cessation of breathing. Contact your doctor immediately if you experience any of these symptoms.

Frequently Asked Question

• How long does  Poractant alfa last?
• The effects of  Poractant alfa typically last for 3 to 5 days. However, some infants may need to receive additional doses.

• Is  Poractant alfa safe for premature infants?
•  Poractant alfa is generally considered safe for premature infants. However, it is important to note that it can cause side effects, such as bradycardia, hypotension, and hypoxemia.

• What happens if my infant needs more than one dose of  Poractant alfa?
• If your infant needs more than one dose of  Poractant alfa, they may be at an increased risk of side effects. However, the benefits of receiving  Poractant alfa often outweigh the risks.

• What are the long-term risks of  Poractant alfa?
• The long-term risks of  Poractant alfa are not fully known. However, there is no evidence that it causes any long-term problems.

• What is the prognosis of   Poractant alfa for infants with RDS?
• The prognosis for infants with RDS has improved significantly in recent years. With proper treatment, most infants with RDS make a full recovery.

• How does  Poractant alfa compare to other synthetic surfactants?
•  Poractant alfa is similar to other synthetic surfactants in terms of its effectiveness in treating RDS. However, it is known to cause less bradycardia and hypotension than other synthetic surfactants.